Correlation between Overweight, Obesity, Gestational Diabetes Mellitus, Adipokines (Adipolin and Adiponectin), and Adverse Pregnancy Outcomes: A Pilot Study

• Published in: Medicina (Kaunas, Lithuania) Vol. 60; no. 9; p. 1544
• Main Authors: Mihai, Muntean, Vladut, Săsăran, Sonia-Teodora, Luca, Laura Mihaela, Suciu, Victoria, Nyulas, Irina Elena, Muntean, Claudiu, Mărginean
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 20-09-2024; MDPI
• Subjects: adipokines; Adipokines - blood; Adiponectin - blood; Adult; Body fat; Body Mass Index; Cardiovascular disease; Case-Control Studies; Cesarean section; Complications and side effects; Congenital diseases; Cytokines; Development and progression; Diabetes; Diabetes in pregnancy; Diabetes, Gestational - blood; Diabetes, Gestational - epidemiology; DNA methylation; Exercise; Female; Gestational age; gestational diabetes mellitus; Glucose; Glucose Tolerance Test - methods; Health aspects; Health care; Humans; Hypertension; Infant, Newborn; Inflammation; Insulin resistance; Metabolism; newborn; Obesity; Obesity - blood; Obesity - complications; Overweight; Overweight - blood; Overweight - complications; Physiological aspects; Pilot Projects; Preeclampsia; Pregnancy; Pregnancy Outcome - epidemiology; Pregnant women; Prospective Studies; Proteins; Risk factors; Tumor necrosis factor-TNF; Womens health; Romania; Europe; adipokines; gestational diabetes mellitus; newborn; overweight; obesity
• ISSN: 1648-9144; 1010-660X; 1648-9144
• DOI: 10.3390/medicina60091544

: The prevalence of overweight (OW), obesity (OB), and gestational diabetes mellitus (GDM) has been increasing worldwide in recent years. Adipolin is a new adipokine with reduced circulating levels in obesity and type 2 diabetes mellitus (T2DM).
: Our prospective case-control study aimed to evaluate the maternal serum levels of adipolin and adiponectin, metabolic parameters, and anthropometric characteristics at the time of oral glucose tolerance test (OGTT) in pregnant women with a pre-pregnancy body mass index (BMI) ≥ 25 Kg/m
and correlate them with newborn adipolin, adiponectin levels, and anthropometric characteristics of the newborns, and secondly to evaluate pregnancy outcomes.
: After the OGTT results, we had 44 OW/OB pregnant women with GDM, 30 OW/OB pregnant women without GDM, and 92 lean healthy (LH) pregnant women. Data were analyzed by ANOVA and correlation tests, with a
-value < 0.05 considered significant.
: We found no differences between adipolin values of the OW/OB pregnant women with GDM and the LH group (
> 0.99), OW/OB without GDM and the LH group (
= 0.56), and between OW/OB groups (
= 0.57). OW/OB pregnant women with GDM had a higher rate of gestational hypertension compared with the LH group (
< 0.0001). Newborns from OW/OB pregnant women with GDM were more frequently diagnosed with jaundice (
= 0.02), and they required more frequent admission to the neonatal intensive care unit (NICU) for treatment of respiratory distress (
= 0.01) compared with newborns from LH mothers.
: Our study revealed that the serum levels of adipolin in the second trimester among the group of OW/OB pregnant women with GDM, matched for age and BMI with OW/OB pregnant women without GDM, were not significantly different. This suggests that adipolin may not play an essential role in the occurrence of GDM in these patients. Despite good glycemic control during pregnancy, OW/OB pregnant women with GDM and their newborns tend to have more complications (gestational hypertension, jaundice, NICU admission) than LH pregnant women and their newborns, highlighting the importance of weight control before pregnancy.